Mississippi, FDA urge people to stop ingesting livestock deworming medicine to fight COVID-19
Researchers are studying what effects, if any, human versions of the lice and topical skin medicine ivermectin has against COVID-19, but health officials are warning people to stop buying and ingesting versions of the drug meant to deworm cows and horses. Mississippi's Department of Health said last Friday that 70 percent of recent calls to the state poison control center were related to people who ingested livestock ivermectin, which can cause a rash, vomiting, abdominal pain, neurological disorders, severe hepatitis, coma, or even death.
Most of the Mississippi ivermectin calls involved people with mild symptoms, but at least one person has reportedly been hospitalized for ivermectin toxicity. "You wouldn't get your chemotherapy at a feed store," Mississippi State Health Officer Dr. Thomas Dobbs said in a Zoom call last week. "I mean, you wouldn't want to treat your pneumonia with your animal's medication. It can be dangerous to get the wrong doses of medication, especially for something that's meant for a horse or a cow."
"You are not a horse," the Food and Drug Administration tweeted over the weekend, linking to a fact sheet on ivermectin. "You are not a cow. Seriously, y'all. Stop it." The fact sheet noted that ivermectin is not an anti-viral, isn't approved for COVID-19, and it "can interact with other medications, like blood-thinners."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Mississippi, with 36.8 percent of its population fully vaccinated, has a higher vaccination rate than only one state, Alabama, NPR notes. The rising use of ivermectin tracks a surge in the Delta strain of the coronavirus in the South and other parts of the country.
Meanwhile, few people are taking advantage of an FDA-approved treatment for early COVID-19 infections, monoclonal antibodies, which "are free to patients" and mostly free of side effects, The Washington Post reports. "They are accessible on an outpatient basis, via a single infusion or four injections. Hospitals, urgent-care centers and even private doctors are authorized to dispense them."
Former President Donald Trump was treated with Regeneron's monoclonal antibodies when he was hospitalized with a serious COVID-19 infection in October 2020, before they were available to the public, and Florida Gov. Ron DeSantis (R) and Texas Gov. Greg Abbott (R) are pushing the treatment in their states; Abbott even took Regeneron's monoclonal antibodies after testing positive earlier this month. The Biden administration is expanding access to monoclonal antibodies but has focused its public outreach on promoting the vaccines.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The mental health crisis affecting vets
Under The Radar Death of Hampshire vet highlights mental health issues plaguing the industry
By Chas Newkey-Burden, The Week UK Published
-
The Onion is having a very ironic laugh with Infowars
The Explainer The satirical newspaper is purchasing the controversial website out of bankruptcy
By Justin Klawans, The Week US Published
-
'Rahmbo, back from Japan, will be looking for a job? Really?'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published